Dr Lal PathLabs Q1FY25: Revenue jumps 11.3%, PAT 29.1%

Dr Lal PathLabs Limited has announced financial results for Q1 FY25

Consolidated revenue increased by 11.3% to Rs 602 crore in Q1 FY25 against Rs 541 crore in Q1 FY24.

PAT increased by 29.1% to Rs 108 crore in Q1 FY25 as against Rs 84 crore in Q1 FY24.

EBITDA increased by 16.2% to Rs 170 crore in Q1 FY25 as against Rs 146 crore in Q1 FY24.

Dr Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network. As of March 31, 2024, the company has 280 clinical laboratories (including the National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore & Mumbai), 5,762 Patient Service Centers (PSCs), and 11,619 Pick-up Points (PUPs). Its customers include individual patients, hospitals, other healthcare providers, and corporate customers.
MB Bureau